Nisa Investment Advisors
ANRO icon

Nisa Investment Advisors’s Alto Neuroscience ANRO Stock Holding History

Nisa Investment Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.6K Hold
338
– – ﹤0.01% 2334
2025
Q4 		$6.02K Hold
338
– – ﹤0.01% 2409
2025
Q3 		$1.36K Sell
338
-78
-19% -$259 ﹤0.01% 2691
2025
Q2 		$915 Buy
416
+175
+73% +$416 ﹤0.01% 2755
2025
Q1 		$521 Buy
+241
New +$862 ﹤0.01% 2784
2024
Q4 		– Sell
-7
Closed -$80 – 3062
2024
Q3 		$80 Buy
+7
New +$86 ﹤0.01% 2920

Other funds holding ANRO

AWG
Alpha Wave Global New York $791M AUM 113.77% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
SSC
Spruce Street Capital New York $416M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nisa Investment Advisors's ANRO Position: Q1 2026 in Review

Nisa Investment Advisors held its Alto Neuroscience (ANRO) position steady in Q1 2026 at 338 shares worth $7.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2334.

Nisa Investment Advisors first reported a position in ANRO in Q3 2024 and has held it in 6 quarters since. 110 funds tracked by Wall St. Rank hold ANRO as of Q1 2026.

  • Nisa Investment Advisors held 338 shares of Alto Neuroscience worth $7.6K as of Q1 2026.
  • Nisa Investment Advisors left its Alto Neuroscience share count unchanged in Q1 2026.
  • Alto Neuroscience made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2334 holding.
  • Nisa Investment Advisors first reported a position in Alto Neuroscience in Q3 2024 and has held it in 6 quarters since.
  • 110 funds tracked by Wall St. Rank held Alto Neuroscience as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.